Patients with metastatic colorectal cancer characteristics according to Th17 level within expanded T cells (Pre-REP) (low vs high) (n=35)
| Th17 low | Th17 high | P value | |
| Patients | |||
| Age at surgery, median (min−max) (years) | 68(50–84) | 67(44–82) | |
| Gender, n (%) | 0.99 | ||
| Male | 13 (37) | 8 (23) | |
| Female | 8 (23) | 6 (17) | |
| Primary cancer | |||
| Location, n (%) | 0.72 | ||
| Colon | 13 (37) | 10 (29) | |
| Rectum | 8 (23) | 4 (11) | |
| Metastases | |||
| Occurrence, n (%) | 0.68 | ||
| Synchronous | 17 (49) | 10 (29) | |
| Metachronous | 4 (11) | 4 (11) | |
| Neoadjuvant chemotherapy, n (%) | 0.16 | ||
| No | 6 (17) | 1 (3) | |
| Chemotherapy | 11 (32) | 7 (20) | |
| Chemotherapy+anti -VEGF | 4 (11) | 6 (17) | |
| RAS mutation, n (%) | 0.49 | ||
| No | 10 (29) | 7 (20) | |
| Yes | 9 (25) | 7 (20) | |
| Unknown | 2 (6) | 0 (0) |